ZEO Scientifix FY26 Q2 net loss widens to $997,000; revenue more than doubles to $2.58 million

ZEO SCIENTIFIX INC

ZEO SCIENTIFIX INC

ZEOX

0.00
  • ZEO Scientifix posted revenue of USD 2.58 million, more than doubled, for the quarter ended April 30, 2026.
  • Gross profit rose to USD 2.06 million, lifting gross margin to 79.6% from 77.7%, while cost of revenues increased to USD 526,000.
  • Net loss widened to USD 997,000 for the six months ended April 30, 2026, with net cash used in operating activities of USD 609,000.
  • Cash climbed to USD 1.85 million at period end from USD 221,000 at the start, supported by USD 1.94 million in financing cash flow.
  • Business update: SB 1768 in Florida is expected to boost demand; an IRB-approved PPX study targets up to 350 patients, with seven enrolled.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-006486), on June 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.